Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Agilent Plans to Invest US$22M to Expand its Newport Plant
The expansion plans involve several components such as the addition of new reactors, the decommissioning of an old reactor, and the establishment of new production laboratories
Boehringer Ingelheim Invests US$314 million (EUR 285 million) to Construct New Chemical Innovation Plant
Boehringer Ingelheim with an investment of US$314 million EUR 285 million plans to build a new Chemical Innovation Plant in Ingelheim, Germany
The University of Kansas Cancer Centre Opens New Cancer Research and Care Facility
The University of Kansas Cancer Centre received US$100 million as a gift from The Sunderland Foundation to construct a stateoftheart cancer centre The facility will be located in USA
Novo Nordisk Invests US$2.3 billion (DKK 15.9 billion) to Expand Manufacturing Facilities
Novo Nordisk plans for the expansion of current Active Pharmaceutical Ingredient API production facility in Denmark This expansion supports the development of future portfolio of treatments for serious chronic diseases
Chongqing Zhifei Invests US$13 milion (100 million RMB) to Open Innovative Product Incubation Centre in China
Chongqing Zhifei plans for the construction of new innovative product incubation centre
WuXi Biologics Expands Drug Manufacturing Capacity
WuXi Biologics plans to expand manufacturing capacity for drug substance and drug product
Chugai Pharmaceutical Invests US$0.35 billion (50 billion Yen) to Open New Manufacturing Facilities
Chugai Pharmaceutical has unveiled its plans to construct a new facility dedicated to the manufacturing of bioactive pharmaceutical ingredients APIs as well as an injection building The two facilities will be loacted in Japan
GenScript Biotech Expands New Manufacturing Facility in China
GenScript Biotech plans for the expansion of new manufacturing facility at Jiangsu, China The facility supports the oligonucleotide and peptide production
TriLink BioTechnologies to Open mRNA Manufacturing Facility
TriLink BioTechnologies plans to construct new mRNA manufacturing capabilities to serve latephase drug developers in the field of life sciences
GeminiBio Plans to Contruct New Liquid Manufacturing Facility
GeminiBio opens new cGMP bioprocess liquid manufacturing facility in California, USA
